Buy Ledviclear : Ledipasvir & Sofosbuvir Tablets Online
Brand Name : Ledviclear
International Trade Name : Harvoni
Composition : Ledipasvir & Sofosbuvir
Manufactured by : Abbott India Ltd.
Strength : Ledipasvir 90 mg and Sofosbuvir 400 mg
Form : Tablets
Packing : Pack of 28 Tablets
Prescription Required *
Ledviclear is a prescription medication used to treat chronic hepatitis C viral infections. It is a combination of two antiviral drugs, ledipasvir and sofosbuvir, that work together to prevent the replication of the hepatitis C virus in the body.
Ledviclear, also known by its international trade name Harvoni, contains two active ingredients: ledipasvir and sofosbuvir. Each tablet of Ledviclear contains Ledipasvir 90 mg and Sofosbuvir 400 mg.
Ledviclear is used to treat chronic hepatitis C viral infections in adults. It may be prescribed for patients with or without liver cirrhosis. Ledviclear can help to prevent the progression of the disease and may lead to a sustained virological response (SVR), which means that the virus is no longer detectable in the patient’s blood.
How to use Ledviclear:
Ledviclear should be taken as prescribed by your doctor. The tablets should be swallowed whole and not crushed or chewed. It is important to take Ledviclear with food, as this can improve the absorption of the drugs. It is important to take Ledviclear consistently at the same time each day to maintain the effectiveness of the medication.
The recommended dose of Ledviclear is one tablet once a day. The duration of treatment can vary depending on the patient’s individual circumstances, such as the extent of liver damage and the patient’s response to the medication. The treatment duration is usually between 8 to 24 weeks. Your doctor will determine the appropriate dosage and duration of treatment for you.
Ledviclear should be stored at room temperature, away from direct sunlight and moisture. Keep it out of reach of children and pets.
Mechanism of Action:
Ledipasvir and sofosbuvir work together to prevent the replication of the hepatitis C virus in the body. Ledipasvir works by inhibiting the action of a protein that the virus uses to reproduce, while sofosbuvir works by inhibiting the action of the virus’s RNA polymerase, which is required for viral replication.
Ledviclear should not be taken by pregnant or breastfeeding women, as it may harm the developing fetus or nursing infant. It may also cause serious side effects in patients with liver or kidney disease. Patients who are allergic to ledipasvir or sofosbuvir should not take Ledviclear.
Ledviclear is contraindicated for patients with severe liver or kidney disease. It should also be avoided in patients who are allergic to ledipasvir or sofosbuvir.
Ledviclear may interact with other medications, especially those that affect the liver, such as rifampin, carbamazepine, and phenytoin. It may also interact with drugs that affect heart rate, such as amiodarone. Always inform your doctor of any medications you are taking before starting treatment with Ledviclear.
In the event of an overdose, contact your doctor or seek emergency medical attention immediately. Symptoms of overdose may include confusion, dizziness, and nausea.
Common side effects of Ledviclear include headache, fatigue, diarrhea, and nausea. Serious side effects may include liver damage, kidney problems, and signs of an allergic reaction. If you experience any unusual symptoms while taking Ledviclear, seek medical attention immediately.